The expanding role of somatostatin analogues in the treatment of neuroendocrine tumours: the CLARINET study

被引：8
作者：
Kaltsas, Gregory [1 ]
Grossman, Ashley B. [2 ]
机构：
[1] Natl Tech Univ Athens, Dept Pathophysiol, Athens 11527, Greece
[2] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
来源：
CLINICAL ENDOCRINOLOGY | 2015年 / 83卷 / 06期
关键词：
PROGNOSTIC-FACTORS; RECEPTOR BIOLOGY; EXPRESSION; SCINTIGRAPHY; MANAGEMENT; EVEROLIMUS; UPDATE;
D O I：
10.1111/cen.12831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：759 / 761
页数：3
相关论文
共 19 条
  • [1] Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors
    Asnacios, Amani
    Courbon, Frederic
    Rochaix, Philippe
    Bauvin, Eric
    Cances-Lauwers, Valerie
    Susini, Christiane
    Schulz, Stefan
    Boneu, Andree
    Guimbaud, Rosine
    Buscail, Louis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 963 - 970
  • [2] Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2-clinical implications
    Cakir, Mehtap
    Dworakowska, Dorota
    Grossman, Ashley
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) : 2585 - 2591
  • [3] Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1-molecular pathways
    Cakir, Mehtap
    Dworakowska, Dorota
    Grossman, Ashley
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (11) : 2570 - 2584
  • [4] Caplin ME, 2014, NEW ENGL J MED, V371, P1556, DOI [10.1056/NEJMc1409757, 10.1056/NEJMoa1316158]
  • [5] Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
    Grozinsky-Glasberg, Simona
    Shimon, Ilan
    Korbonits, Marta
    Grossman, Ashley B.
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (03) : 701 - 720
  • [6] The diagnosis and medical management of advanced neuroendocrine tumors
    Kaltsas, GA
    Besser, GM
    Grossman, AB
    [J]. ENDOCRINE REVIEWS, 2004, 25 (03) : 458 - 511
  • [7] Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas
    Kouvaraki, MA
    Ajani, JA
    Hoff, P
    Wolff, R
    Evans, DB
    Lozano, R
    Yao, JG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4762 - 4771
  • [8] Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
    Kwekkeboom, Dik J.
    Kam, Boen L.
    van Essen, Martijn
    Teunissen, Jaap J. M.
    van Eijck, Casper H. J.
    Valkema, Roelf
    de Jong, Marion
    de Herder, Wouter W.
    Krenning, Eric P.
    [J]. ENDOCRINE-RELATED CANCER, 2010, 17 (01) : R53 - R73
  • [9] THE CLINICAL USE OF SOMATOSTATIN ANALOGS IN THE TREATMENT OF CANCER
    LAMBERTS, SWJ
    KRENNING, EP
    KLIJN, JGM
    REUBI, JC
    [J]. BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1990, 4 (01): : 29 - 49
  • [10] Guidelines for Acromegaly Management: An Update
    Melmed, S.
    Colao, A.
    Barkan, A.
    Molitch, M.
    Grossman, A. B.
    Kleinberg, D.
    Clemmons, D.
    Chanson, P.
    Laws, E.
    Schlechte, J.
    Vance, M. L.
    Ho, K.
    Giustina, A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (05) : 1509 - 1517
12